|
US5389632A
(en)
|
1992-02-24 |
1995-02-14 |
Laboratoires Upsa |
Pyrazolopyrimidine derivatives which are angiotensin II receptor antagonists
|
|
WO1995035298A1
(en)
|
1994-06-21 |
1995-12-28 |
Otsuka Pharmaceutical Factory, Inc. |
PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE
|
|
HU229024B1
(en)
|
1996-07-24 |
2013-07-29 |
Bristol Myers Squibb Pharma Co |
Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof
|
|
US20010007867A1
(en)
|
1999-12-13 |
2001-07-12 |
Yuhpyng L. Chen |
Substituted 6,5-hetero-bicyclic derivatives
|
|
CA2379585C
(en)
|
1999-09-30 |
2006-06-20 |
James W. Darrow |
Certain alkylene diamine-substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines
|
|
ES2277855T3
(es)
|
1999-09-30 |
2007-08-01 |
Neurogen Corporation |
Pirazolo-(1,5-a)-1,5-pirimidinas y pirazolo-(1,5-a)-1,3,5-triazinas amino sustituidas.
|
|
JP2002308879A
(ja)
|
2001-04-13 |
2002-10-23 |
Nippon Soda Co Ltd |
５−ハロアルキル−アゾロピリミジン化合物、製造方法及び有害生物防除剤
|
|
US7662826B2
(en)
|
2002-04-23 |
2010-02-16 |
Shionogi & Co., Ltd. |
Pyrazolo [1,5-a] pyrimidine derivative and nad (p) h oxidase inhibitor containing the same
|
|
JP2005529919A
(ja)
|
2002-05-10 |
2005-10-06 |
スミスクライン ビーチャム コーポレーション |
治療用化合物
|
|
AU2003240488A1
(en)
|
2002-06-04 |
2003-12-19 |
Neogenesis Pharmaceuticals, Inc. |
Pyrazolo` 1,5a! pyrimidine compounds as antiviral agents
|
|
US7205308B2
(en)
|
2002-09-04 |
2007-04-17 |
Schering Corporation |
Trisubstituted 7-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors
|
|
US7161003B1
(en)
|
2002-09-04 |
2007-01-09 |
Schering Corporation |
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
|
US7563798B2
(en)
|
2002-09-04 |
2009-07-21 |
Schering Corporation |
Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
|
|
US7196078B2
(en)
*
|
2002-09-04 |
2007-03-27 |
Schering Corpoartion |
Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
|
US7119200B2
(en)
|
2002-09-04 |
2006-10-10 |
Schering Corporation |
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
|
DE60313872T2
(de)
*
|
2002-09-04 |
2008-01-17 |
Schering Corp. |
Pyrazoloä1,5-aüpyrimidine als hemmstoffe cyclin-abhängiger kinasen
|
|
US7605155B2
(en)
*
|
2002-09-04 |
2009-10-20 |
Schering Corporation |
Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
|
|
MXPA05002571A
(es)
*
|
2002-09-04 |
2005-09-08 |
Schering Corp |
Pirazolopirimidinas como inhibidores de cinasa dependientes de ciclina.
|
|
US8580782B2
(en)
|
2002-09-04 |
2013-11-12 |
Merck Sharp & Dohme Corp. |
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
|
|
GB0305559D0
(en)
|
2003-03-11 |
2003-04-16 |
Teijin Ltd |
Compounds
|
|
US20070179161A1
(en)
*
|
2003-03-31 |
2007-08-02 |
Vernalis (Cambridge) Limited. |
Pyrazolopyrimidine compounds and their use in medicine
|
|
WO2004089471A2
(en)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
NEW PYRAZOLO[1,5-a] PYRIMIDINES DERIVATIVES AND PHARMACEUTICAL USE THEREOF
|
|
US7501405B2
(en)
|
2003-04-11 |
2009-03-10 |
High Point Pharmaceuticals, Llc |
Combination therapy using an 11β-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent for the treatment of metabolic syndrome and related diseases and disorders
|
|
JP2005008581A
(ja)
|
2003-06-20 |
2005-01-13 |
Kissei Pharmaceut Co Ltd |
新規なピラゾロ［１，５−ａ］ピリミジン誘導体、それを含有する医薬組成物およびそれらの用途
|
|
US20070060595A1
(en)
|
2003-10-10 |
2007-03-15 |
Toshio Yoshizawa |
Novel fused heterocyclic compound and use thereof
|
|
JP2007515474A
(ja)
|
2003-12-22 |
2007-06-14 |
エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド |
Ｃｒｆ受容体アンタゴニストおよびそれらに関連する方法
|
|
US8018479B2
(en)
|
2008-08-27 |
2011-09-13 |
Lexmark International, Inc. |
Method and system for correcting the linearity error in electrophotographic devices
|
|
WO2006016715A1
(ja)
*
|
2004-08-13 |
2006-02-16 |
Teijin Pharma Limited |
ピラゾロ［１，５－ａ］ピリミジン誘導体
|
|
CA2591125A1
(en)
|
2004-12-21 |
2006-06-29 |
Schering Corporation |
Pyrazolo[1,5-a]pyrimidine adenosine a2a receptor antagonists
|
|
DE102005007534A1
(de)
|
2005-02-17 |
2006-08-31 |
Bayer Cropscience Ag |
Pyrazolopyrimidine
|
|
AR057979A1
(es)
|
2005-10-06 |
2008-01-09 |
Schering Corp |
PIRAZOLPIRIMIDINAS COMO INHIBIDORAS DE PROTEíNA QUINASA. COMPOSICIONES FARMACEUTICAS.
|
|
BRPI0616985B1
(pt)
|
2005-10-06 |
2021-10-26 |
Merck Sharp & Dohme Corp. |
Composto de pirazolo[1,5-a]pirimidina, e, uso de um composto
|
|
AR056876A1
(es)
|
2005-10-21 |
2007-10-31 |
Tanabe Seiyaku Co |
Compuestos de pirazolo[1-5-a]pirimidina, antagonistas de receptores canabinoides cb1, composiciones farmaceuticas que los contienen y usos en el tratamiento de enfermedades del sistema nervioso central, tales como trastornos psicoticos, neurologicos y similares
|
|
WO2007109571A2
(en)
|
2006-03-17 |
2007-09-27 |
Prometheus Laboratories, Inc. |
Methods of predicting and monitoring tyrosine kinase inhibitor therapy
|
|
WO2007139732A1
(en)
|
2006-05-22 |
2007-12-06 |
Schering Corporation |
Pyrazolo [1, 5-a] pyrimidines as cdk inhibitors
|
|
AU2008261027A1
(en)
*
|
2007-06-05 |
2008-12-11 |
Emory University |
Selective inhibitors for cyclin-dependent kinases
|
|
CN101784276A
(zh)
|
2007-06-27 |
2010-07-21 |
传染性疾病研究院 |
化合物在用于制备抗结核药剂中的用途
|
|
US20110201599A1
(en)
*
|
2008-07-03 |
2011-08-18 |
Exelixis, Inc. |
CDK Modulators
|
|
JP5578490B2
(ja)
|
2008-12-26 |
2014-08-27 |
味の素株式会社 |
ピラゾロピリミジン化合物
|
|
US8993612B2
(en)
|
2009-10-08 |
2015-03-31 |
Rhizen Pharmaceuticals Sa |
Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer
|
|
JP5802676B2
(ja)
|
2009-12-04 |
2015-10-28 |
センワ バイオサイエンシズ インコーポレイテッド |
Ｃｋ２阻害剤としてのピラゾロピリミジンおよび関連複素環化合物
|
|
ES2540867T3
(es)
|
2010-02-26 |
2015-07-14 |
Mitsubishi Tanabe Pharma Corporation |
Compuestos de pirazolopirimidina y su uso como inhibidores de PDE10
|
|
MY183861A
(en)
|
2010-03-05 |
2021-03-17 |
Kyowa Hakko Kirin Co Ltd |
Pyrazolopyrimidine derivative
|
|
PT3012258T
(pt)
|
2010-06-24 |
2018-12-14 |
Gilead Sciences Inc |
Composição farmacêutica compreendendo um derivado de pirazolo[1,5-a]pirimidina como agente antiviral
|
|
CN110003219A
(zh)
|
2010-07-13 |
2019-07-12 |
弗·哈夫曼-拉罗切有限公司 |
作为irak4调节剂的吡唑并[1,5a]嘧啶和噻吩并[3,2b]嘧啶衍生物
|
|
US8883801B2
(en)
|
2010-08-23 |
2014-11-11 |
Merck Sharp & Dohme Corp. |
Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors
|
|
WO2012044562A2
(en)
|
2010-09-30 |
2012-04-05 |
Merck Sharp & Dohme Corp. |
Pyrazolopyrimidine pde10 inhibitors
|
|
WO2012170827A2
(en)
|
2011-06-08 |
2012-12-13 |
Cylene Pharmaceuticals, Inc. |
Pyrazolopyrimidines and related heterocycles as ck2 inhibitors
|
|
WO2013104611A1
(en)
|
2012-01-10 |
2013-07-18 |
Bayer Intellectual Property Gmbh |
Substituted pyrazolopyrimidines as akt kinase inhibitors
|
|
CN104136399B
(zh)
|
2012-02-17 |
2018-08-07 |
米伦纽姆医药公司 |
泛素活化酶的吡唑并嘧啶基抑制剂
|
|
WO2013130943A1
(en)
|
2012-03-02 |
2013-09-06 |
Genentech, Inc. |
Alkyl-and di-substituted amido-benzyl sulfonamide derivatives
|
|
CA2889919C
(en)
|
2012-11-16 |
2021-08-17 |
University Health Network |
Pyrazolopyrimidine compounds
|
|
BR112015022864A8
(pt)
|
2013-03-14 |
2019-11-26 |
Celtaxsys Inc |
composto, composição farmacêutica e uso dos mesmos
|
|
GB201403093D0
(en)
|
2014-02-21 |
2014-04-09 |
Cancer Rec Tech Ltd |
Therapeutic compounds and their use
|
|
EP3125907A4
(en)
|
2014-04-01 |
2017-11-29 |
Cornell University |
Use of double-stranded dna in exosomes: a novel biomarker in cancer detection
|
|
EP3129371B1
(en)
|
2014-04-05 |
2020-07-29 |
Syros Pharmaceuticals, Inc. |
Inhibitors of cyclin-dependent kinase 7 (cdk7)
|
|
ES2899196T3
(es)
|
2015-03-09 |
2022-03-10 |
Aurigene Discovery Tech Ltd |
Derivados de pirazolo[1,5-a][1,3,5]triazina y de pirazolo[1,5-a]pirimidina como inhibidores de CDK
|
|
USRE50776E1
(en)
*
|
2015-03-27 |
2026-02-03 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinases
|
|
WO2016169995A1
(en)
|
2015-04-20 |
2016-10-27 |
AbbVie Deutschland GmbH & Co. KG |
Substituted pyrazolopyrimidines and method of use
|
|
WO2016201370A1
(en)
*
|
2015-06-12 |
2016-12-15 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy of transcription inhibitors and kinase inhibitors
|
|
EP3356330B1
(en)
|
2015-10-01 |
2019-11-20 |
Bristol-Myers Squibb Company |
Biaryl kinase inhibitors
|
|
JP2018199623A
(ja)
|
2015-10-22 |
2018-12-20 |
大正製薬株式会社 |
含窒素縮合複素環化合物
|
|
SG10201912607SA
(en)
|
2015-11-19 |
2020-02-27 |
Blueprint Medicines Corp |
Compounds and compositions useful for treating disorders related to ntrk
|
|
US11112410B2
(en)
|
2016-04-13 |
2021-09-07 |
President And Fellows Of Harvard College |
Methods for capturing, isolation, and targeting of circulating tumor cells and diagnostic and therapeutic applications thereof
|
|
US20190060296A1
(en)
*
|
2017-07-28 |
2019-02-28 |
Massachusetts Institute Of Technology |
Discovery of small molecules that target the androgen receptor and uses
|
|
SI3658557T1
(sl)
|
2017-07-28 |
2024-10-30 |
Takeda Pharmaceutical Company Limited |
Zaviralci TYK2 in njihova uporaba
|
|
US11155560B2
(en)
*
|
2018-10-30 |
2021-10-26 |
Kronos Bio, Inc. |
Substituted pyrazolo[1,5-a]pyrimidines for modulating CDK9 activity
|